Judy Del Mundo, MD
Allergy/Immunology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 9 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
31 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mundo’s office at (408) 271-8807 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A64233 · Current
Licensed to practise in California · since 1998 · expires 2028-01-31 · Manila Central University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$33,894
Medicare paid this office $33,894 for 75 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 50 | $12,802 | $106 |
| Short return visit (20+ min) | 41 | $5,896 | $72 |
| Test to measure expiratory airflow and volume | 55 | $3,676 | $25 |
| New patient visit (45+ min) | 15 | $2,187 | $146 |
Who their Medicare patients are
75 Original Medicare patients in 2024. Average age 74 · Women 72% · Also on Medicaid 16% · Health risk score 1.21. Above the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 75% · Diabetes 37% · Chronic kidney disease 36% · Coronary heart disease 28% · COPD 23% · Atrial fibrillation 20%.
The office billed $92,180, Medicare allowed $46,786 and paid $33,894; for 1,394 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 75 | 1,394 | 74 | 1.21 | $92,180 | $33,894 |
| 2023 | 70 | 1,246 | 74 | 1.06 | $69,885 | $28,824 |
| 2022 | 65 | 1,564 | 74 | 0.89 | $73,514 | $35,299 |
| 2021 | 66 | 1,555 | 74 | 0.88 | $78,519 | $41,055 |
| 2020 | 62 | 1,456 | 74 | 1.00 | $66,721 | $31,628 |
| 2019 | 60 | 1,889 | 74 | 1.12 | $90,327 | $46,002 |
| 2018 | 68 | 1,435 | 73 | 1.28 | $71,897 | $33,652 |
| 2017 | 55 | 1,061 | 73 | 1.14 | $66,551 | $30,715 |
| 2016 | 53 | 1,352 | 75 | 1.02 | $78,569 | $37,984 |
| 2015 | 46 | 1,329 | 76 | 1.33 | $73,140 | $35,732 |
| 2014 | 49 | 1,227 | 75 | 0.96 | $55,655 | $28,339 |
| 2013 | 53 | 1,536 | 75 | 1.10 | $59,179 | $31,650 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 38 | $8,874 | $104 |
| Short return visit (20+ min) | 51 | $7,432 | $69 |
| Test to measure expiratory airflow and volume | 49 | $3,437 | $24 |
2022: 4 services
| Return visit (30+ min) | 45 | $14,315 | $111 |
| Short return visit (20+ min) | 42 | $6,438 | $76 |
| Test to measure expiratory airflow and volume | 38 | $3,379 | $25 |
| New patient visit (45+ min) | 15 | $1,971 | $131 |
2021: 4 services
| Return visit (30+ min) | 50 | $19,372 | $111 |
| Professional service for preparation and provision of 1 or more antigens | 11 | $6,175 | $14 |
| Short return visit (20+ min) | 39 | $5,076 | $73 |
| Test to measure expiratory airflow and volume | 41 | $4,741 | $29 |
2020: 4 services
| Return visit (30+ min) | 43 | $12,333 | $97 |
| Short return visit (20+ min) | 35 | $3,462 | $56 |
| New patient visit (45+ min) | 14 | $1,717 | $123 |
| Test to measure expiratory airflow and volume | 28 | $1,129 | $29 |
2019: 7 services
| Return visit (30+ min) | 44 | $14,911 | $99 |
| Short return visit (20+ min) | 40 | $8,312 | $63 |
| Test to measure expiratory airflow and volume | 48 | $7,646 | $35 |
| Test for allergy using allergenic extract | 12 | $3,457 | $4 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $1,911 | $62 |
| New patient visit (45+ min) | 13 | $1,858 | $143 |
| Test to measure the level of nitric oxide gas | 24 | $942 | $21 |
2018: 6 services
| Return visit (30+ min) | 42 | $10,218 | $87 |
| Test to measure expiratory airflow and volume | 53 | $6,243 | $33 |
| Short return visit (20+ min) | 45 | $6,165 | $61 |
| New patient visit (45+ min) | 14 | $1,514 | $108 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 12 | $858 | $54 |
| Test to measure the level of nitric oxide gas | 19 | $743 | $20 |
2017: 5 services
| Return visit (30+ min) | 43 | $12,843 | $86 |
| Test to measure expiratory airflow and volume | 46 | $5,731 | $32 |
| Short return visit (20+ min) | 33 | $3,881 | $60 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $1,374 | $55 |
| Test to measure the level of nitric oxide gas | 27 | $1,177 | $18 |
2016: 6 services
| Return visit (30+ min) | 46 | $16,282 | $83 |
| Test to measure expiratory airflow and volume | 46 | $7,270 | $32 |
| Short return visit (20+ min) | 31 | $4,692 | $62 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 23 | $2,158 | $53 |
| New patient visit (45+ min) | 14 | $1,421 | $101 |
| Test to measure the level of nitric oxide gas | 19 | $588 | $18 |
2015: 6 services
| Return visit (30+ min) | 34 | $11,218 | $88 |
| Short return visit (20+ min) | 34 | $7,173 | $62 |
| Test to measure expiratory airflow and volume | 41 | $6,404 | $33 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 20 | $2,507 | $57 |
| New patient visit (45+ min) | 13 | $1,707 | $131 |
| Test to measure the level of nitric oxide gas | 16 | $514 | $19 |
2014: 4 services
| Return visit (30+ min) | 36 | $8,383 | $87 |
| Short return visit (20+ min) | 32 | $5,736 | $60 |
| Test to measure expiratory airflow and volume | 33 | $4,772 | $34 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $1,815 | $59 |
2013: 6 services
| Return visit (30+ min) | 40 | $11,538 | $90 |
| Test for allergy using allergenic extract | 16 | $6,799 | $7 |
| Test to measure expiratory airflow and volume | 33 | $4,176 | $35 |
| Short return visit (20+ min) | 26 | $2,923 | $62 |
| New patient visit (45+ min) | 20 | $2,522 | $126 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $2,034 | $60 |
Medicaid work
$2,172 in 2024
Medicaid paid $2,172 for 410 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 91 | $1,195 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 13 | $375 |
| Short return visit (20+ min) | 149 | $365 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 157 | $238 |
| 2024 | 410 | 4 | 23 | $2,172 |
| 2023 | 646 | 3 | 34 | $995 |
| 2022 | 374 | 3 | 23 | $0 |
| 2021 | 233 | 3 | 25 | $236 |
| 2020 | 65 | 2 | 16 | $0 |
| 2019 | 437 | 3 | 28 | $0 |
| 2018 | 112 | 3 | 19 | $0 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 145 | $728 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 255 | $145 |
| Short return visit (20+ min) | 246 | $122 |
2022
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 143 | $0 |
| Short return visit (20+ min) | 72 | $0 |
| Return visit (30+ min) | 159 | $0 |
2021
| Return visit (30+ min) | 149 | $157 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 71 | $78 |
| Short return visit (20+ min) | 13 | $0 |
2020
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 44 | $0 |
| Return visit (30+ min) | 21 | $0 |
2019
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 197 | $0 |
| New patient visit (30+ min) | 14 | $0 |
| Short return visit (20+ min) | 226 | $0 |
2018
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 42 | $0 |
| New patient visit (30+ min) | 12 | $0 |
| Short return visit (20+ min) | 58 | $0 |
Drugs they prescribed that Part D paid
$116,939
Pharmacies billed $116,939 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 783) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
502 generic and 281 brand-name prescriptions · $116,939 in drug cost · 32 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 65 | $40,703 | $626 |
| Spiriva Respimat | 20 | $12,395 | $620 |
| Symbicort | 30 | $8,914 | $297 |
| Arnuity Ellipta | 29 | $6,676 | $230 |
| Advair Hfa | 21 | $6,457 | $307 |
See all 20 drugs
| Trelegy Ellipta | 65 | $40,703 | $626 |
| Spiriva Respimat | 20 | $12,395 | $620 |
| Symbicort | 30 | $8,914 | $297 |
| Arnuity Ellipta | 29 | $6,676 | $230 |
| Advair Hfa | 21 | $6,457 | $307 |
| Wixela Inhub | 43 | $5,974 | $139 |
| Breyna | 30 | $5,820 | $194 |
| Qvar Redihaler | 15 | $5,556 | $370 |
| Alvesco | 13 | $3,487 | $268 |
| Fluticasone Propionate Hfa | 13 | $2,391 | $184 |
| Fluticasone Propionate | 108 | $1,943 | $18 |
| Fluticasone-Salmeterol | 12 | $1,856 | $155 |
| Montelukast | 140 | $1,765 | $13 |
| Budesonide-Formoterol | 13 | $1,680 | $129 |
| Azelastine | 53 | $1,667 | $31 |
| Albuterol Sulfate Hfa | 46 | $1,125 | $24 |
| Ventolin Hfa | 13 | $729 | $56 |
| Levocetirizine Dihydrochloride | 11 | $114 | $10 |
| Prednisone | 27 | $58 | $2 |
| Azithromycin | 19 | $47 | $2 |
Year by year
| 2024 | 783 | 110 | 0% (0) | 36% | $116,939 |
| 2023 | 719 | 108 | 0% (0) | 34% | $113,695 |
| 2022 | 708 | 92 | 0% (0) | 35% | $107,753 |
| 2021 | 733 | 92 | 0% (0) | 32% | $102,509 |
| 2020 | 673 | 76 | 0% (0) | 33% | $85,712 |
| 2019 | 605 | 70 | 0% (0) | 33% | $75,959 |
| 2018 | 462 | 55 | 0% (0) | 37% | $60,326 |
| 2017 | 559 | 59 | 0% (0) | 39% | $67,025 |
| 2016 | 583 | 49 | 0% (0) | 32% | $58,808 |
| 2015 | 454 | 40 | 0% (0) | 33% | $43,702 |
| 2014 | 353 | 44 | 0% (0) | 28% | $27,366 |
| 2013 | 233 | 42 | 0% (0) | 40% | $17,374 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Symbicort | 74 | $36,990 | $500 |
| Trelegy Ellipta | 26 | $17,873 | $687 |
| Flovent Hfa | 35 | $10,690 | $305 |
| Spiriva Respimat | 13 | $9,870 | $759 |
| Budesonide-Formoterol | 21 | $5,670 | $270 |
| Wixela Inhub | 23 | $3,705 | $161 |
| Qvar Redihaler | 15 | $3,198 | $213 |
| Fluticasone Propionate | 106 | $2,654 | $25 |
| Azelastine | 64 | $2,249 | $35 |
| Montelukast | 117 | $1,882 | $16 |
| Fluticasone-Salmeterol | 12 | $1,767 | $147 |
| Albuterol Sulfate Hfa | 47 | $1,507 | $32 |
| Levocetirizine Dihydrochloride | 24 | $466 | $19 |
| Azithromycin | 29 | $202 | $7 |
| Prednisone | 32 | $164 | $5 |
2022: 15 drugs
| Symbicort | 67 | $34,673 | $518 |
| Spiriva Respimat | 19 | $12,049 | $634 |
| Flovent Hfa | 40 | $11,756 | $294 |
| Advair Diskus | 22 | $10,339 | $470 |
| Budesonide-Formoterol | 12 | $4,224 | $352 |
| Qvar Redihaler | 19 | $4,081 | $215 |
| Azelastine | 67 | $3,043 | $45 |
| Wixela Inhub | 23 | $2,721 | $118 |
| Fluticasone Propionate | 125 | $2,658 | $21 |
| Albuterol Sulfate Hfa | 55 | $2,289 | $42 |
| Montelukast | 127 | $1,773 | $14 |
| Fluticasone-Salmeterol | 13 | $1,763 | $136 |
| Levocetirizine Dihydrochloride | 11 | $305 | $28 |
| Prednisone | 27 | $107 | $4 |
| Azithromycin | 14 | $81 | $6 |
2021: 16 drugs
| Symbicort | 59 | $30,358 | $515 |
| Spiriva Respimat | 15 | $9,574 | $638 |
| Flovent Hfa | 30 | $8,397 | $280 |
| Breo Ellipta | 16 | $7,895 | $493 |
| Budesonide-Formoterol | 22 | $5,902 | $268 |
| Advair Diskus | 11 | $5,680 | $516 |
| Qvar Redihaler | 23 | $5,050 | $220 |
| Wixela Inhub | 23 | $3,972 | $173 |
| Azelastine | 76 | $3,247 | $43 |
| Epinephrine | 13 | $3,240 | $249 |
| Fluticasone-Salmeterol | 16 | $3,061 | $191 |
| Montelukast | 158 | $2,114 | $13 |
| Fluticasone Propionate | 108 | $1,851 | $17 |
| Albuterol Sulfate Hfa | 32 | $1,226 | $38 |
| Prednisone | 45 | $181 | $4 |
| Azithromycin | 14 | $62 | $4 |
2020: 14 drugs
| Symbicort | 58 | $28,032 | $483 |
| Spiriva Respimat | 18 | $10,320 | $573 |
| Qvar Redihaler | 40 | $9,128 | $228 |
| Advair Hfa | 13 | $6,727 | $517 |
| Breo Ellipta | 13 | $4,680 | $360 |
| Budesonide-Formoterol | 14 | $3,532 | $252 |
| Azelastine | 60 | $2,918 | $49 |
| Wixela Inhub | 14 | $1,865 | $133 |
| Montelukast | 142 | $1,831 | $13 |
| Fluticasone Propionate | 108 | $1,738 | $16 |
| Albuterol Sulfate Hfa | 24 | $1,240 | $52 |
| Olopatadine | 17 | $721 | $42 |
| Prednisone | 46 | $191 | $4 |
| Azithromycin | 28 | $173 | $6 |
2019: 11 drugs
| Symbicort | 77 | $30,905 | $401 |
| Spiriva Respimat | 18 | $9,314 | $517 |
| Advair Hfa | 12 | $9,159 | $763 |
| Qvar Redihaler | 29 | $6,199 | $214 |
| Advair Diskus | 15 | $5,762 | $384 |
| Azelastine | 56 | $1,966 | $35 |
| Montelukast | 141 | $1,816 | $13 |
| Fluticasone Propionate | 61 | $770 | $13 |
| Ventolin Hfa | 12 | $743 | $62 |
| Azithromycin | 47 | $361 | $8 |
| Prednisone | 47 | $229 | $5 |
2018: 7 drugs
| Symbicort | 85 | $30,991 | $365 |
| Advair Diskus | 12 | $4,881 | $407 |
| Montelukast | 106 | $1,687 | $16 |
| Azelastine | 27 | $1,209 | $45 |
| Fluticasone Propionate | 46 | $683 | $15 |
| Prednisone | 49 | $275 | $6 |
| Azithromycin | 27 | $174 | $6 |
2017: 11 drugs
| Symbicort | 88 | $30,484 | $346 |
| Qvar | 36 | $7,662 | $213 |
| Advair Hfa | 13 | $5,521 | $425 |
| Advair Diskus | 11 | $3,987 | $362 |
| Montelukast | 154 | $2,218 | $14 |
| Azelastine | 34 | $2,078 | $61 |
| Ventolin Hfa | 14 | $763 | $55 |
| Fluticasone Propionate | 57 | $700 | $12 |
| Proair Hfa | 12 | $681 | $57 |
| Prednisone | 40 | $251 | $6 |
| Azithromycin | 30 | $216 | $7 |
2016: 11 drugs
| Symbicort | 61 | $22,632 | $371 |
| Advair Diskus | 16 | $5,375 | $336 |
| Advair Hfa | 11 | $3,742 | $340 |
| Qvar | 13 | $2,573 | $198 |
| Montelukast | 179 | $2,419 | $14 |
| Azelastine | 43 | $1,926 | $45 |
| Fluticasone Propionate | 60 | $716 | $12 |
| Proair Hfa | 12 | $651 | $54 |
| Prednisone | 40 | $259 | $6 |
| Azithromycin | 30 | $233 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $148 | $13 |
2015: 11 drugs
| Symbicort | 42 | $14,059 | $335 |
| Qvar | 20 | $4,629 | $231 |
| Advair Hfa | 14 | $4,349 | $311 |
| Azelastine | 36 | $2,811 | $78 |
| Montelukast | 115 | $1,852 | $16 |
| Proair Hfa | 13 | $670 | $52 |
| Fluticasone Propionate | 52 | $663 | $13 |
| Theophylline Anhydrous | 12 | $324 | $27 |
| Prednisone | 42 | $303 | $7 |
| Azithromycin | 27 | $199 | $7 |
| Levocetirizine Dihydrochloride | 12 | $177 | $15 |
2014: 11 drugs
| Symbicort | 37 | $10,412 | $281 |
| Qvar | 17 | $3,796 | $223 |
| Montelukast | 73 | $1,962 | $27 |
| Azelastine | 15 | $1,400 | $93 |
| Fluticasone Propionate | 50 | $943 | $19 |
| Proair Hfa | 12 | $635 | $53 |
| Triamcinolone Acetonide | 15 | $351 | $23 |
| Theophylline Anhydrous | 18 | $327 | $18 |
| Prednisone | 32 | $282 | $9 |
| Levocetirizine Dihydrochloride | 16 | $277 | $17 |
| Azithromycin | 20 | $182 | $9 |
2013: 6 drugs
| Symbicort | 20 | $4,578 | $229 |
| Montelukast | 37 | $1,185 | $32 |
| Levocetirizine Dihydrochloride | 20 | $883 | $44 |
| Fluticasone Propionate | 23 | $876 | $38 |
| Azithromycin | 23 | $255 | $11 |
| Prednisone | 26 | $134 | $5 |
Money from drug and device companies
$800 in 2025
| 2025 | 14 | 37 | None | $800 |
| 2024 | 8 | 30 | None | $596 |
| 2023 | 6 | 35 | None | $738 |
| 2022 | 10 | 35 | None | $627 |
| 2021 | 7 | 34 | None | $650 |
| 2020 | 7 | 32 | None | $834 |
| 2019 | 7 | 27 | None | $988 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Fasenra | $317 | 10 payments
|
| Galderma Laboratories L.P. | Nemluvio | $79 | 3 payments
|
| CSL Behring | Hizentra | $56 | 2 payments
|
| ARS Pharmaceuticals Operations | Neffy | $54 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $51 | 2 payments
|
| Novartis Pharmaceuticals | Rhapsido | $37 | 2 payments
|
See all 29 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-04 | Tezspire | $32 |
| Paratek Pharmaceuticals | Meals · 2025-11-13 | Xhance | $24 |
| Galderma Laboratories L.P. | Meals · 2025-11-11 | Nemluvio | $24 |
| Novartis Pharmaceuticals | Meals · 2025-11-07 | Rhapsido | $22 |
| CSL Behring | Meals · 2025-11-05 | Hizentra | $33 |
| Galderma Laboratories L.P. | Meals · 2025-10-31 | Nemluvio | $30 |
| Incyte | Meals · 2025-09-27 | Opzelura | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | Fasenra | $27 |
| GlaxoSmithKline | Meals · 2025-09-09 | Trelegy Ellipta | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-09 | Airsupra | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-09 | Airsupra | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-28 | Tezspire | $33 |
| CSL Behring | Meals · 2025-07-22 | Hizentra | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-15 | Fasenra | $28 |
| ARS Pharmaceuticals Operations | Meals · 2025-07-08 | Neffy | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-17 | Airsupra | $27 |
| Galderma Laboratories L.P. | Meals · 2025-04-30 | Nemluvio | $26 |
| Kowa Pharmaceuticals America | Meals · 2025-04-25 | Zoryve | $19 |
| Lilly USA | Meals · 2025-04-24 | Ebglyss | $32 |
| Novartis Pharmaceuticals | Meals · 2025-04-22 | None | $15 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-20 | Takhzyro | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-20 | Takhzyro | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-15 | Airsupra | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-03-05 | Dupixent | $26 |
| ARS Pharmaceuticals Operations | Meals · 2025-02-25 | Neffy | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-17 | Fasenra | $64 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-14 | Tezspire | $31 |
| Optinose US | Meals · 2025-02-10 | Xhance | $19 |
| Organon | Meals · 2025-01-17 | Vtama | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $596
| AstraZeneca Pharmaceuticals LP | Tezspire | $260 | 7 payments
|
| GlaxoSmithKline | Nucala | $173 | 7 payments
|
| Genzyme | Dupixent | $55 | 2 payments
|
| Greer Laboratories | Oralair | $29 | 1 payment
|
| Optinose US | Xhance | $24 | 1 payment
|
| Octapharma USA | Cutaquig | $24 | 1 payment
|
| Grifols USA | Xembify | $17 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $15 | 1 payment
|
2023: $738
| GlaxoSmithKline | Trelegy Ellipta | $336 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $200 | 6 payments
|
| Genzyme | Dupixent | $92 | 3 payments
|
| Greer Laboratories | Oralair | $45 | 1 payment
|
| Grifols USA | Xembify | $43 | 2 payments
|
| ALK-Abello | Odactra | $21 | 1 payment
|
2022: $627
| AstraZeneca Pharmaceuticals LP | Fasenra | $187 | 7 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $145 | 7 payments
|
| Genzyme | Dupixent | $69 | 2 payments
|
| Covis Pharma GmBH | Alvesco | $60 | 1 payment
|
| kaleo | Auvi-Q | $43 | 2 payments
|
| Amgen | Tezspire | $33 | 1 payment
|
| Pfizer | Cibinqo | $32 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $22 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $20 | 1 payment
|
| ALK-Abello | Odactra | $17 | 1 payment
|
2021: $650
| GlaxoSmithKline | Nucala | $198 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $189 | 8 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $105 | 4 payments
|
| ALK-Abello | None | $65 | 1 payment
|
| Pfizer | Eucrisa | $53 | 2 payments
|
| Genzyme | Dupixent | $22 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $18 | 1 payment
|
2020: $834
| AstraZeneca Pharmaceuticals LP | Fasenra | $420 | 16 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $97 | 4 payments
|
| GlaxoSmithKline | Nucala | $83 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $79 | 3 payments
|
| ALK-Abello | Odactra | $75 | 1 payment
|
| Pfizer | Eucrisa | $52 | 2 payments
|
| Aimmune Therapeutics | Palforzia | $27 | 1 payment
|
2019: $988
| AstraZeneca Pharmaceuticals LP | Fasenra | $439 | 13 payments
|
| GlaxoSmithKline | Nucala | $265 | 4 payments
|
| Pfizer | Eucrisa | $99 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $83 | 2 payments
|
| Greer Laboratories | Oralair | $48 | 2 payments
|
| Kaleo | Auvi-Q | $36 | 2 payments
|
| Circassia Pharmaceuticals | Niox Vero | $19 | 1 payment
|
Professional record
- NPI
- 1942203013
- Licence
- CA A64233California A64233: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207K00000X (207K00000X)
- Mailing address
- 2061 Clarmar Way, Ste A, San Jose, CA, 95128
- NPI first listed
- 2005-05-23
- NPI last updated
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.